112 related articles for article (PubMed ID: 725257)
1. Studies on the 5-HT receptor in vascular smooth muscle.
Müller-Schweinitzer E
Res Clin Stud Headache; 1978; 6():6-12. PubMed ID: 725257
[TBL] [Abstract][Full Text] [Related]
2. Vascular effects of ergot alkaloids: a study on human basilar arteries.
Müller-Schweinitzer E
Gen Pharmacol; 1983; 14(1):95-102. PubMed ID: 6826043
[TBL] [Abstract][Full Text] [Related]
3. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):41-4. PubMed ID: 1004641
[TBL] [Abstract][Full Text] [Related]
4. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
Glusa E; Markwardt F
Pharmacology; 1984; 29(6):336-42. PubMed ID: 6505006
[TBL] [Abstract][Full Text] [Related]
5. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.
Glusa E; Roos A
Br J Pharmacol; 1996 Sep; 119(2):330-4. PubMed ID: 8886417
[TBL] [Abstract][Full Text] [Related]
6. Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.
Mylecharane EJ; Spira PJ; Misbach J; Duckworth JW; Lance JW
Eur J Pharmacol; 1978 Mar; 48(1):1-9. PubMed ID: 416960
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology of ergotamine and dihydroergotamine.
Silberstein SD
Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
[TBL] [Abstract][Full Text] [Related]
8. On the pharmacology of venous smooth muscle from dog and man.
Müller-Schweinitzer E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
10. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):113-8. PubMed ID: 940593
[TBL] [Abstract][Full Text] [Related]
13. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
Müller-Schweinitzer E; Rosenthaler J
J Cardiovasc Pharmacol; 1987 Jun; 9(6):686-93. PubMed ID: 2442535
[TBL] [Abstract][Full Text] [Related]
14. Antimigraine drug interactions with 5-hydroxytryptamine1A receptors.
Hiner BC; Roth HL; Peroutka SJ
Ann Neurol; 1986 May; 19(5):511-3. PubMed ID: 2940961
[TBL] [Abstract][Full Text] [Related]
15. Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
Looper ML; Edrington TS; Moubarak AS; Callaway TR; Rosenkrans CF
Foodborne Pathog Dis; 2008 Oct; 5(5):599-604. PubMed ID: 18681792
[TBL] [Abstract][Full Text] [Related]
16. Effects on arterial receptors of ergot derivatives used in migraine.
Müller-Schweinitzer E; Fanchamps A
Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
[No Abstract] [Full Text] [Related]
17. [Serotonin agonists and antagonists in migraine].
Ollat H
Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
19. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
den Boer MO; Heiligers JP; Saxena PR
Br J Pharmacol; 1991 Sep; 104(1):183-9. PubMed ID: 1664762
[TBL] [Abstract][Full Text] [Related]
20. [Comparative responsiveness of isolated saphenous, femoral and external carotid arteries and veins of dogs to dihydroergotamine mesylate (DEM) (author's transl)].
Fukawa K; Honda H; Kubota H; Hatanaka Y; Sawabe T
Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):223-30. PubMed ID: 7327451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
